Background Image
Table of Contents Table of Contents
Previous Page  42 / 70 Next Page
Information
Show Menu
Previous Page 42 / 70 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 5, September/October 2016

312

AFRICA

(ES)] end-systolic longitudinal strain [SLSC (ES)] and positive

peak transverse strain (STSR peak P).

Segmental analysis showed that end-systolic longitudinal

strain [STSR (ES)] measurements of the basal posterior and

mid-posterior segments were statistically significantly lower

in the patient group (

p

<

0.05). End-systolic longitudinal

displacement [DLDC (ES)] of the basal posterior, mid-posterior

and mid-anterior septal segments were statistically significantly

lower in the patient group (

p

<

0.05).

Discussion

Wilson’s disease is an autosomal recessive inherited disease,

characterised by excessive copper storage in the body, especially

the liver and brain, and also in the heart tissue due to reduced

biliary copper excretion secondary to loss of the mutation

for copper-transporting ATPase (ATP7B). Wilson’s disease,

characterised by excessive copper deposition in the body,

primarily in the liver and brain, results from an inability of the

liver to excrete copper in the bile.

1,2

Cardiac involvement of Wilson’s disease has not been

sufficiently investigated. Electrocardiographic abnormalities,

cardiac arrhythmias, cardiomyopathy, autonomic dysfunction

and sudden cardiac death are rare complications but may be seen

in children with Wilson’s disease due to copper accumulation in

the heart tissue.

3-5

Arat

et al

. showed increased P-wave dispersion in adults

with cardiologically asymptomatic Wilson’s disease.

6

In another

study on adults, electrocardiographic abnormalities, including

left ventricular hypertrophy, early repolarisation, biventricular

hypertrophy, premature atrial or ventricular contractions, atrial

fibrillation, sino-atrial block and Mobitz type 1 atrioventricular

block were detected in 34% of the patients.

6

Electrocardiographic

abnormalities are not uncommon in Wilson’s disease and are

presumably related to an underlying cardiomyopathy due to

deposition of copper in the heart.

5

We previously evaluated 22 children with Wilson’s disease

with 24-hour ECG monitoring and our study showed that

one patient had first-degree atrioventricular block, one had

frequent sinus exit block, and four had rare ventricular ectopic

beat.

8

In our study, all the patients were assessed with ECG

before echocardiographic evaluation. Only one patient had

Wolf–Parkinson–White pattern, but there were no arrhythmias

or ECG abnormalities in any of the patients. We assumed that

ECG abnormalities develop over a long period or in untreated

patients.

The major pathological findings of the myocardium in

Wilson’s disease included the presence of interstitial and

myocardial fibrosis, focal myocarditis and cardiac hypertrophy,

conduction tissue degeneration, and early atherosclerosis due

to the toxic effect of copper, leading to mitochondrial injury

and lipid peroxidation, which is caused by reactive free oxygen

radicals. Hlubocka

et al

. suggested that cardiac changes seen in

Wilson’s disease are not only related to copper accumulation

but also to free oxygen radicals.

9

Therefore echocardiography is

an important tool to assess asymptomatic Wilson’s patients. In

this study, left ventricular wall thickness was increased and left

ventricular end-diastolic diameter was decreased in patients with

Wilson’s disease and the differences were statistically comparable

to the results of the control group. Measurement of local and

global myocardial function using non-invasive methods is a

major aim in clinical cardiology.

10

Cardiac systolic function may

deteriorate in prolonged disease or in untreated patients.

Table 7. Longitudinal and transverse strain and strain rate values

according to segment from the two-chamber view

Strain according to

segment

Patients (

n

=

21)

(mean

±

SD)

Controls (

n

=

20)

(mean

±

SD)

p

-value

SLSC peak G (%)

Basal inferior

–21.80

±

4.37

–21.14

±

6.86

0.70

Mid-inferior

–21.24

±

3.56

–20.69

±

6.95

0.73

Apical inferior

–17.40

±

3.73

–17.65

±

6.61

0.87

Apical anterior

–11.41

±

4.04

–12.17

±

5.90

0.62

Mid-anterior

–18.00

±

3.33

–14.97

±

6.23

0.047

Basal anterior

–22.22

±

5.04

–18.75

±

7.16

0.06

SLSC peak S (%)

Basal inferior

–21.75

±

0.35

–21.20

±

6.26

0.73

Mid-inferior

–21.18

±

3.61

–20.62

±

6.99

0.73

Apical inferior

–16.97

±

3.72

–17.34

±

7.44

0.83

Apical anterior

–10.99

±

3.97

–11.75

±

6.44

0.63

Mid-anterior

–17.72

±

3.30

–14.78

±

6.65

0.06

Basal anterior

–21.82

±

4.94

–18.35

±

7.63

0.07

SLSC peak P (%)

Basal inferior

0.33

±

0.49

0.62

±

1.034

0.23

Mid-inferior

0.06

±

0.18

0.52

±

1.98

0.27

Apical inferior

0.46

±

0.66

1.03

±

3.14

0.39

Apical anterior

0.65

±

1.11

1.01

±

2.53

0.55

Mid-anterior

0.20

±

0.52

0.55

±

1.67

0.35

Basal anterior

0.61

±

1.50

0.63

±

1.18

0.95

STSR peak P (%)

Basal inferior

30.87

±

12.70

30.60

±

11.08 0.93

Mid-inferior

24.16

±

8.65

26.84

±

9.22

0.32

Apical inferior

20.89

±

7.31

26.22

±

11.44 0.06

Apical anterior

21.55

±

13.51

29.40

±

16.40 0.09

Mid-anterior

25.47

±

23.34

35.20

±

21.54 0.15

Basal anterior

30.20

±

30.81

41.83

±

26.16 0.180

STSR peak G (%)

Basal inferior

–21.55

±

4.19

–20.82

±

6.76

0.66

Mid-inferior

–21.09

±

3.52

–20.40

±

7.23

0.68

Apical inferior

–16.92

±

3.72

–17.32

±

7.19

0.81

Apical anterior

–10.92

±

3.95

–11.73

±

6.37

0.61

Mid-anterior

–17.53

±

3.26

–14.735

±

6.58

0.07

Basal anterior

–21.61

±

5.00

–18.36

±

7.37

0.09

SLSC (ES) (%)

Basal inferior

24.62

±

16.37

25.58

±

13.77 0.83

Mid-inferior

21.18

±

10.41

24.35

±

11.35 0.33

Apical inferior

19.02

±

8.22

24.90

±

12.82 0.07

Apical anterior

18.972

±

13.33

28.12

±

17.37 0.05

Mid-anterior

19.41

±

23.34

33.33

±

22.37 0.047

Basal anterior

19.51

±

32.88

38.74

±

26.77 0.038

STSR (ES) (%)

Basal inferior

13.93

±

3.22

13.21

±

4.30

0.53

Mid-inferior

7.70

±

1.99

7.55

±

2.58

0.82

Apical inferior

2.06

±

0.97

2.14

±

1.27

0.811

Apical anterior

1.67

±

1.15

1.67

±

1.83

0.999

Mid-anterior

5.69

±

1.81

5.24

±

3.03

0.55

Basal anterior

12.19

±

2.72

10.50

±

4.68

0.14

DLDC (ES) (mm)

Basal inferior

4.40

±

1.88

4.46

±

2.09

0.91

Mid-inferior

4.07

±

1.71

3.89

±

1.83

0.72

Apical inferior

2.49

±

1.42

2.54

±

1.30

0.90

Apical anterior

1.42

±

0.94

1.64

±

1.04

0.45

Mid-anterior

2.58

±

1.57

2.5523

±

1.75

0.94

Basal anterior

5.59

±

2.74

5.00

±

2.96

0.48

SLSC peak G: the most negative peak longitudinal strain, SLSC peak S: negative

systolic peak longitudinal strain, SLSC peak P: positive systolic peak longitudinal

strain, SLSC (ES): end-systolic longitudinal strain, STSR peak P: positive peak

transverse strain, STSR peak G: the most negative peak transverse strain, STSR

(ES): end-systolic longitudinal strain, DLDC (ES): end-systolic longitudinal

displacement.